期刊文献+

腹膜后局限性CastLeman病4例报告并文献复习 被引量:2

Retroperitoneal local CastLeman's disease: 4 case reports and literature review
原文传递
导出
摘要 目的:报告偶然发现的4例腹膜后局限性CastLeman病,并结合文献复习,以提高对该疾病的认识及诊疗水平。方法:回顾性分析4例术前未能明确诊断的后腹膜占位性病变病例,经手术切除,术后病理证实为较少见的局限性CastLeman病。结果:4例均经手术完整切除肿瘤,未行辅助治疗,随访7个月~4年2个月,4例患者均无瘤存活,未见肿瘤复发。结论:腹膜后CastLeman病临床症状不典型,术前实验室及影像学检查无特异性,常易误诊。手术探查切除肿瘤为首选治疗方法,疗效较好,最终明确诊断有赖于病理学检查。 Objective:We reported the incidentally found 4 cases of retroperitoneal the local CastLeman's dis- ease and undertook a literature review to improve the diagnosis and treatment of the disease. Method: Retrospec- tively analyzed 4 cases with retroperitoneal mass which failed to confirm the diagnosis before surgery. After surgi- cal resection, the pathological results were local CastLeman's disease. Result: All 4 cases received complete surgical resection of the tumor. No adjuvant therapy was administrated. Follow-up ranged form 4 months to 4 years and 2 months. No recurrence was observed. Conclusion: Retroperitoneal CastLeman's disease has no typical clinical find- ings. It may pose a diagnose dilemma because of its lack of specific lab test and distinguish radiographic features. Surgical exploration to remove the tumor is the preferred treatment with fair outcome. Eventually confirming diag- nosis depends on the pathological examination.
出处 《临床泌尿外科杂志》 2013年第2期133-135,共3页 Journal of Clinical Urology
关键词 CASTLEMAN病 诊断 治疗 CastLeman disease diagnosis treatment
  • 相关文献

参考文献11

  • 1赵晨晖,周文龙,张志伟,王名伟,黄滔.腹膜后局限型Castleman病2例报告及文献复习[J].现代泌尿生殖肿瘤杂志,2011,3(2):77-79. 被引量:3
  • 2宋科,蓝儒竹.Castleman病1例报告[J].现代泌尿生殖肿瘤杂志,2011,3(6):360-360. 被引量:3
  • 3肖峻,陈凌武,郑伏甫,吴荣佩,陈炜,丘少鹏,林焕懿.腹膜后局限性Castleman病误诊嗜铬细胞瘤4例并文献复习[J].现代泌尿生殖肿瘤杂志,2012,4(1):10-12. 被引量:6
  • 4Powles T, Stebbing J, Montoto S, et al. Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease[J]. Blood, 2007, 110.. 4132-4133. 被引量:1
  • 5Chen C H, Liu H C, Tung K Y, et al. Surgical out- come of superficial and deep Castleman disease[J]. ANZ J Surg, 2007, 77: 339-343. 被引量:1
  • 6Kawabata H, Tomosugi N, Kanda J, et al. Anti-inter- leukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castle- man's disease[J]. Haematologica, 2007, 92: 857- 858. 被引量:1
  • 7Beck J T, Hsu S M, Wijdenes J, et al. Brief report: alleviation of systemic manifestations of Castleman's disease by monoelonal anti-interleukin-6 antibody[J]. N EnglJ Med, 1994, 330.. 602-605. 被引量:1
  • 8Dham A, Peterson B A. Castleman disease[J]. Curr Opin Hematol, 2007, 14: 354-359. 被引量:1
  • 9Chronowski G M, Ha C S, Wilder R B, et al. Treat- ment of unicentric and multicentric Castleman disease and the role of radiotherapy[J]. Cancer, 2001, 92.. 670 -676. 被引量:1
  • 10Bestawros A, Michel R, Seguin C, et al. Multieentric Castleman's disease treated with combination chemo- therapy and rituximab in four HIV-positive men: a case series[J]. Am J Hematol, 2008, 83.. 508-511. 被引量:1

二级参考文献32

  • 1刘芳,李红华,金斗,杜广清,于力.4例Castleman病临床观察及文献分析[J].中国临床医学,2007,14(2):270-272. 被引量:14
  • 2Newlon JL,Couch M,Brennan J.Castleman's disease:three case reports and a review of the literature[J].Ear Nose Throat J,2007,86(7):414-418. 被引量:1
  • 3Bowne WB,Lewis JJ,Filippa DA,et al.The management of unicentric and multicentric Castleman's disease:a report of 16 cases and a review of the literature[J].Cancer,1999,85(3):706-717. 被引量:1
  • 4Chronowski GM,Ha CS,Wilder RB,et al.Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy[J].Cancer,2001,92(3):670-676. 被引量:1
  • 5Herrada J,Cabanillas F,Rice L,et al.The clinical 0 behavior of localized and multicentric Castleman disease[J].Ann Intern Med,1998,128(8):657-662. 被引量:1
  • 6Powles T,Stebbing J,Montoto S,et al.Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease[J].Blood,2007,110(12):4132-4133. 被引量:1
  • 7Dispenzieri A,Gertz MA.Treatment of Castleman's disease[J].Curr Treat Options Oncol,2005,6(3):255-266. 被引量:1
  • 8Baserga M,Rosin M,Schoen M,et al.Muhifocal Castleman disease in pediatrics:case report[J].J Pediatr Hematol Oncol,2005,27(12):666-669. 被引量:1
  • 9Kawabata H,Tomosugi N,Kanda J,et al.Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease[J].Haematologica,2007,92(6):857-858. 被引量:1
  • 10Zoeteweij JP,Eyes ST,Orenstein JM,et al.Identification and rapid quantification of early-and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis:characterization of antiherpesvirus agents[J].J Virol,1999,73(7):5894-5902. 被引量:1

共引文献7

同被引文献16

  • 1Saeed-Abdul-Rahman 1, Al-Arnri A M. Castleman disease[J]. Korean I Hemato1.2012,47(3) :163-177. 被引量:1
  • 2Dossier A, Meignin V, Fieschi C, et a1. Human herpesvirus 8-re1ated Castleman disease in the absence of HIV infection[J]. Clin Infect Dis,2013,56(6) :833-842. 被引量:1
  • 3Kawabata H,Kotani Sv Matsumura Y,et al. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using to- cilizumab , an anti-interl eukin-f receptor anti body [J]. Intern Med, 2013,52 (13) : 1503 - 1507. 被引量:1
  • 4Zeng M,Zhang M,Hu W,et a1. A case of para neoplastic pemphigus associated with Castleman's disease[J]. An Bras Dcrmatol, 2013,88 (6 Supplll:11-14. 被引量:1
  • 5Gill M K,Suri V,Dubey V K,et a1. Cytological diagnosis of Castleman's disease of the soft tissue[J]. j Cytol,2013,30(3) :213-215. 被引量:1
  • 6Seirafi P A, Ferguson E, Edwards F H. Thoracoscopic resection of Castleman disease: case report and review free to view [J]. Chest J aunary , 2003,123 (1) : 280 - 282. 被引量:1
  • 7lang S M, Han H ,jang K S, et al. Castleman's disease of the renal sinus presenting as a urothelial malignancy: a brief case report[J]. Korean] Pathol,2012,46(5) :503--506,. 被引量:1
  • 8Erkan N, Yildirim M, Selek E, et al. Peripancreatic Castleman disease[J].]OP,2004,5(6) :491-494. 被引量:1
  • 9Kim U, Hwang I M. Optic Neuropathy associated with Castleman disease[J]. Korean I OphthalmoI,2010,24(4) :256-259. 被引量:1
  • 10Awano N, Inomata M, Kondoh K, et al. Mixed-type multicentric Castleman's disease developing during a 17-year follow-up of sarcoidosis[J]. Inter Med, 2012,51 (2ll : 3061 - 3066. 被引量:1

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部